Dan Stanton

B2B journo focused on biopharma & bioprocessing industry. Information is not knowledge, knowledge is not wisdom. Opinions are all mine and probably not yours

[Dan Stanton @Dan5tanton]

2 things i said i wouldn't do in 2024: a) use Musk' toXic Twitter platform and b) go to #CPHImilan #CPHI . Well here i am. As are 40,000 others all trying to get in

[Dan Stanton @Dan5tanton]

Large crowd at #BPIeurope attending the LiveLabs tour... currentluly hearing about @benchling process management software offerings

[Dan Stanton @Dan5tanton]

if you aint an insider then you're an outsider... or @BioProInsider team hard at work at ##BPIEUROPE

[Dan Stanton @Dan5tanton]

With over 30 years of scories experience at @Boehringer Uwr Buecheler talks paradigm shift in biologic manufacturing at ##BPIEUROPE in Vienna

[Dan Stanton @Dan5tanton]

Roche' Jose Ortiz Tena kicks off the manufacturing strategy track at #BPieurope saying this is the track where the upstream and downstream processes come together, with tech and data management ever more critical in the bioprocess space

[Dan Stanton @Dan5tanton]

On a plane headed to Vienna and missing the #BPIeurope predat workshops... however a little bird told me the Tech Transfer stream is at full capacity, which may shine some light on what tickles the bioprocess industry's tummy right now

[Dan Stanton @Dan5tanton]

On my way from Paris to Vienna Austria for another #BPIeurope and thanks to the good people at @AirFranceFR i'm about to enter the upstream!!! (That's a very weak bioprocess-y joke right there)

[Dan Stanton @Dan5tanton]

It's been a long time (pre Elon) since I've been on Twitter / X. Anyone still use this platform for #biopharma trade events eg #BPIeurope or is it just for MAGA lovers and culture wars?

[Dan Stanton @Dan5tanton]

Bringing the Pall portfolio under the Cytiva brand will bring customers simpler and greater access to bioprocess technologies and services, claims Danaher, though no comment on potential synergies and cost-savings. https://t.co/e7JWqM2wdT

[Dan Stanton @Dan5tanton]

Acquisition-hungry Danaher Corporation could continue to eye-up #CDMO opportunities despite reports it has given up on Catalent Pharma Solutions. Read my comment piece on why Danaher may be eying up other CDMO targets below https://t.co/x0VrodDhVD

[Dan Stanton @Dan5tanton]

The US FDA has approved Gamida Cell’s Omisirge (omidubicel), an allogeneic cell therapy for patients with blood cancers who are set to undergo stem cell transplantation.

https://t.co/Pie3074bXq

[Dan Stanton @Dan5tanton]

Biogen will develop and commercialise an Alzheimer’s candidate using Denali’s Antibody Transport Vehicle (ATV)., writes reporter Anna Brown for BioProcess International https://t.co/TLyKNYXHeI

[Dan Stanton @Dan5tanton]

#CDMO Catalent’s stock price drops 26% as capacity ramp-up delays at a gene therapy plant in Maryland add to ongoing operational issues at sites in Indiana and Belgium. https://t.co/GZjadtJAow

[Dan Stanton @Dan5tanton]

Less than three years after Thermo Fisher launched cell therapy services from the site, the #cdmo is closing its Princeton, New Jersey facility citing changing manufacturing demands. https://t.co/QvkDeKyqAT

[Dan Stanton @Dan5tanton]

In what has become a highlight of Phacilitate’s #advancedtherapiesweek, @susanbnichols , chief business officer at ViroCell Biologics, highlighted 10 events from 2022 that drove conversation, investment, and innovation in the #cell…https://t.co/eZS6PtMk0k https://t.co/VLQ8S3eHi7

[Dan Stanton @Dan5tanton]

The cell and gene therapy pioneer and living legend Carl June just have a fantastic history of CAR-T and lessons learned since the first patients were dosed 10 years ago.

so many takeaways but love the fact CAR-Ts were originally referred to as RAT-Ts !…https://t.co/FdM4za49uy

[Dan Stanton @Dan5tanton]

where are the opportunities for growth in cell amd gene therapy manufacturing? Dominic Clarke 's awesome slide at #atw2023 shows the main interlinking areas industry must embrace

#advancedtherapiesweek https://t.co/TXePD6GM8r

[Dan Stanton @Dan5tanton]

where are the opportunities for growth in cell amd gene therapy manufacturing? Dominic Clarke 's awesome slide at #atw2023 shows the main interlinking areas industry must embrace

#advancedtherapiesweek https://t.co/IOUh1aSpBU

[Dan Stanton @Dan5tanton]

With cell and gene therapies coming of age, experts at #advancedtherapiesweek looked to reducing COGs, novel payer models, and even biosimilars to tackle their spiraling price tags.

Anthony Davies from Dark Horse Consulting Group…https://t.co/FVo0eGHTm3 https://t.co/F7nW666ePX

[Dan Stanton @Dan5tanton]

@Phacilitate Because I behaved and didn't drink too much, I need to know where tomorrow morning's fun run starts from and at what time!!! (Also, you handing out free t shirts? haha) The agenda doesn't really say. Thanks! #AdvancedTherapiesWeek #ATW2023